Cue Biopharma, Inc., 2026-07-22
An SEC Form D private-offering notice from Boston, MA, a $49,999,927 filer-stated offering target in Biotech. Filed 2026-07-22. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biopharmaceutical company developing Immuno STAT biologic therapeutics that selectively modulate T cells for autoimmune disease and immuno oncology; publicly traded on Nasdaq as CUE.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Carnot Labs, Inc., 2026-07-23, $5M, Charlestown, MA
- BioGene Therapeutics Inc., 2026-07-23, $4.5M, Austin, TX
- CSA Medical, Inc., 2026-07-23, $11.2M, Lexington, MA
- DIGITAL ETHER COMPUTING, LLC, 2026-07-22, $2M, Jacksonville Beach, FL
- BluStream Corp, 2026-07-22, $1.4M, Worcester, MA
- TYBR Health, Inc., 2026-07-22, $30M, Houston, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.